Biogen Inc. buy Cantor Fitzgerald
Start price
09.09.24
/
50%
€181.30
Target price
09.09.25
€264.32
Performance (%)
-32.63%
End price
10.09.25
€122.15
Summary
This prediction ended on 10.09.25 with a price of €122.15. The BUY prediction by Cantor_Fitzgerald for Biogen Inc. performed very badly with a performance of -32.63%. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 2.184% | 2.184% | 44.537% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $292.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten